Graham Q2 FY2027: Margin Jumps to 28.2%, Guidance Mix Raised, Record $561M Backlog
GHM sits 32% above its 52-week low of $52.57.
Summary
Graham's Q2 FY2027 10-Q confirms 6% sales growth to $69.8M with gross margin up to 28.2%, and raises the full-year gross profit outlook while keeping sales and adjusted EBITDA guidance unchanged. Cash stands at $71.4M with no debt and a record $561.3M backlog.
Key Events · Earnings and Guidance · GHM
-
Q2 Sales Up 6%, Margin Jumps
Net sales were $69,760 versus $66,027 a year ago, and gross profit rose 38% to $19,673 as gross margin expanded to 28.2% from 21.7%.
-
Guidance Mix Raised, Top Line Held
FY2027 gross profit guidance lifted to 25.0%-26.0% of sales from 24.5%-25.5%, SG&A raised to 17.5%-18.5% from 16.5%-17.5%, and capex trimmed to $15,000-$20,000 from $18,000-$22,000; sales of $285,000-$295,000 and adjusted EBITDA of $35,000-$40,000 are unchanged.
-
Cash Swells, Debt Eliminated
Cash and equivalents reached $71,427 versus $6,580 at March 31, 2026, with no debt outstanding and $74,736 available on the $80,000 revolver after the $50,000 April PIPE.
-
Record Backlog, Softer Orders
Backlog hit a record $561,276, up 12% year over year, but Q2 orders of $73,701 fell 11% and the book-to-bill ratio was 1.1x.
Analysis · GHM · Technology
The headline numbers were already out via this morning's 8-K, but the 10-Q adds the detail that matters: gross margin jumped to 28.2% from 21.7%, and management raised its full-year gross profit outlook to 25.0%-26.0% of sales while lifting the SG&A ratio target to 17.5%-18.5%. Sales ($285M-$295M) and adjusted EBITDA ($35M-$40M) ranges were left unchanged, so the mix shift is the story — better gross profit partly offset by heavier spending on people, processes and technology. The balance sheet is transformed: $71.4M of cash versus $6.6M at March 31 after the $50M T. Rowe Price PIPE and full debt repayment, with $74.7M still available on the revolver. Backlog hit a record $561.3M, though Q2 orders of $73.7M were down 11% year over year, so bookings bear watching into the seasonally weak fiscal third quarter.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GHM was trading at $69.59 on NYSE in the Technology sector, with a market capitalization of approximately $816M. The 52-week trading range was $52.57 to $125.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.